Anticoagulant therapy in a patient with a history of cerebral hemorrhage


View Publication Info
Field Value
Title Anticoagulant therapy in a patient with a history of cerebral hemorrhage
Creator Crisci, Mario
Description Several guidelines recommend the preferential use of NOAC compared to warfarin in patients with atrial fibrillation, based on evidence to support a efficacy similar to warfarin, but with a lower incidence of intracranial hemorrhage. The case described is a typical example of non-optimal use of NOACs in clinical practice: although the final choice of dabigatran 110 mg bid is in line with the recommendations of the guidelines and with the literature, the previous choice of administering enoxaparin is inadequate due to the presence of atrial fibrillation which makes the use of the drug off-label due to the lack of clinical data in this type of patient. Nevertheless, use of enoxaparin waiting to optimize anticoagulant therapy is very common in clinical practice. Non-inferiority in reagards to thromboembolic events and a superior safety profile in comparison to warfarin in the RE-LY study, make dabigatran 110 mg bid a suitable choice in clinical practice for patients at high risk of both thrombotic and hemorrhagic stroke (Cardiology).
Publisher Aboutscience Srl
Date 2018-11-05
Type info:eu-repo/semantics/article
Case report
Format application/pdf
Source AboutOpen; V. 4 N. 1 (2018): January - December 2018; 191-195
AboutOpen; Vol 4 No 1 (2018): January - December 2018; 191-195
Language eng
Rights Copyright (c) 2018 The authors

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library